| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LXFR | Ordinary Shares | Options Exercise | +1,285 | +4.2% | 31,979 | 10 Jun 2024 | Direct | F1 | ||
| transaction | LXFR | Ordinary Shares | Options Exercise | +199 | +0.62% | 32,178 | 10 Jun 2024 | Direct | F1 | ||
| transaction | LXFR | Ordinary Shares | Options Exercise | +2,315 | +7.2% | 34,493 | 10 Jun 2024 | Direct | F1 | ||
| transaction | LXFR | Ordinary Shares | Options Exercise | +800 | +2.3% | 35,293 | 10 Jun 2024 | Direct | F1 | ||
| transaction | LXFR | Ordinary Shares | Options Exercise | +87 | +0.25% | 35,380 | 10 Jun 2024 | Direct | F1 | ||
| transaction | LXFR | Ordinary Shares | Options Exercise | +1,280 | +3.6% | 36,660 | 10 Jun 2024 | Direct | F1 | ||
| transaction | LXFR | Ordinary Shares | Options Exercise | +1,000 | +2.7% | 37,660 | 10 Jun 2024 | Direct | F1 | ||
| transaction | LXFR | Ordinary Shares | Options Exercise | +83 | +0.22% | 37,743 | 10 Jun 2024 | Direct | F1 | ||
| transaction | LXFR | Ordinary Shares | Options Exercise | +1,150 | +3% | 38,893 | 10 Jun 2024 | Direct | F1 | ||
| transaction | LXFR | Ordinary Shares | Options Exercise | +55 | +0.14% | 38,948 | 10 Jun 2024 | Direct | F1 | ||
| transaction | LXFR | Ordinary Shares | Tax liability | $48,187 | -4,172 | -11% | $11.55 | 34,776 | 10 Jun 2024 | Direct | |
| holding | LXFR | Ordinary Shares | 7,520 | 10 Jun 2024 | By Spouse |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LXFR | Stock Options (Right to Buy) | Options Exercise | -1,285 | -100% | 0 | 10 Jun 2024 | Ordinary Shares | 1,285 | Direct | F1, F2 | |||
| transaction | LXFR | Dividend Equivalent Rights | Options Exercise | -199 | -100% | 0 | 10 Jun 2024 | Ordinary Shares | 199 | Direct | F3 | |||
| transaction | LXFR | Stock Options (Right to Buy) | Options Exercise | -2,315 | -100% | 0 | 10 Jun 2024 | Ordinary Shares | 2,315 | Direct | F1, F4 | |||
| transaction | LXFR | Stock Options (Right to Buy) | Options Exercise | -800 | -50% | 800 | 10 Jun 2024 | Ordinary Shares | 800 | Direct | F1, F5 | |||
| transaction | LXFR | Dividend Equivalent Rights | Options Exercise | -87 | -49% | 92 | 10 Jun 2024 | Ordinary Shares | 87 | Direct | F3 | |||
| transaction | LXFR | Stock Options (Right to Buy) | Options Exercise | -1,280 | -50% | 1,280 | 10 Jun 2024 | Ordinary Shares | 1,280 | Direct | F1, F6 | |||
| transaction | LXFR | Stock Options (Right to Buy) | Options Exercise | -1,000 | -33% | 2,000 | 10 Jun 2024 | Ordinary Shares | 1,000 | Direct | F1, F7 | |||
| transaction | LXFR | Dividend Equivalent Rights | Options Exercise | -83 | -25% | 254 | 10 Jun 2024 | Ordinary Shares | 83 | Direct | F3 | |||
| transaction | LXFR | Stock Options (Right to Buy) | Options Exercise | -1,150 | -25% | 3,450 | 10 Jun 2024 | Ordinary Shares | 1,150 | Direct | F1, F8 | |||
| transaction | LXFR | Dividend Equivalent Rights | Options Exercise | -55 | -24% | 172 | 10 Jun 2024 | Ordinary Shares | 55 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. |
| F2 | Represents the exercise of time-based Stock Options awarded on March 13, 2020. The subject Stock Options fully vested and were exercisable as of March 13, 2024. The time-based Stock Options are fully vested and exercised. |
| F3 | Represents dividend equivalent rights accrued on employee Stock Options, which become exercisable proportionately with the Stock Options to which they relate. Each dividend equivalent right is the economic equivalent of one Ordinary Share. The subject dividend equivalent rights convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. |
| F4 | Represents the exercise of performance-based Stock Options (at 50% target) awarded on March 13, 2020. One-half of the performance-based Stock Options vested and became exercisable on March 13, 2023 upon achievement of relative Total Shareholder Return (TSR) goals for the performance period ended December 31, 2022, and the remaining balance vested on March 13, 2024. The performance-based Stock Options are fully vested and exercised. |
| F5 | Represents the exercise of time-based Stock Options awarded on March 15, 2021. The subject Stock Options vested and were exercisable as of March 15, 2024. The remaining Stock Options vest and become exercisable on March 15, 2025. |
| F6 | Represents the exercise of performance-based Stock Options (at 200% target) awarded on March 15, 2021. One-third of the performance-based Stock Options vested and became exercisable on March 15, 2023 upon the achievement of an adjusted diluted EPS performance measure for the performance period ended December 31, 2021. A further one-third of the performance-based Stock Options vested on March 15, 2024, and the remaining balance will vest and become exercisable on March 15, 2025. |
| F7 | Represents the exercise of time-based Stock Options awarded on March 14, 2022. The subject Stock Options vested and were exercisable as of March 14, 2024. The remaining Stock Options vest and become exercisable in two equal annual installments on March 14, 2025 and March 14, 2026. |
| F8 | Represents the exercise of time-based Stock Options awarded on March 20, 2023. The subject Stock Options vested and were exercisable as of March 20, 2024. The remaining Stock Options vest in three equal annual installments beginning on March 20, 2025. |
Managing Director, Luxfer MEL Technologies